# DZX Mediated Insulin Suppression in Obese Men

> **NCT00631033** · PHASE2 · COMPLETED · sponsor: **Rijnstate Hospital** · enrollment: 51 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Placebo
- **DRUG:** Diazoxide
- **DRUG:** Metformin + Diazoxide

## Key facts

- **NCT ID:** NCT00631033
- **Lead sponsor:** Rijnstate Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2014-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631033, "DZX Mediated Insulin Suppression in Obese Men". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00631033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*